![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Approves Smart Device for Accurate Placement of Epidural Injections
FDA Approves Smart Device for Accurate Placement of Epidural Injections
Omeq Medical’s EpiFinder — which assists physicians to accurately position an epidural needle for spinal anesthesia — has received regulatory clearance from the FDA.
The current technique — loss of resistance in the epidural space — has been used for epidurals since the 1920s and fails in up to 30 percent of patients, the company said.
EpiFinder is a single-use epidural placement device that integrates with the standard loss of resistance technique and monitors tissue resistance at the needle tip to accurately detect needle penetration into the epidural space.
A clinical study conducted by Omeq resulted in successful epidural blocks in all 31 patients in the study.
Related Topics
Upcoming Events
-
11Jul
-
18Jul
-
21Oct